Article
RUNX1 Mutations in the Leukemic Progression of Severe Congenital Neutropenia.
Molecules and cells - 29 Feb 2020
Olofsen Patricia A, Touw Ivo P
Abstract excerpt
Somatic RUNX1 mutations are found in approximately 10% of patients with de novo acute myeloid leukemia (AML), but are more common in secondary forms of myelodysplastic syndrome (MDS) or AML. Particularly, this applies to MDS/AML developing from certain types of leukemia-prone inherited bone marrow failure syndromes. How these RUNX1 mutations contribute to the pathobiology of secondary MDS/AML is still unknown....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
